Schonfeld Strategic Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,340	Closed	-$237K	–	2175
2025 Q2	$237K	Buy	+10,340	New	+$257K	﹤0.01%	1746
2025 Q1	–	Sell	-42,614	Closed	-$1.58M	–	2188
2024 Q4	$1.58M	Buy	42,614 +33,007	+344%	+$1.51M	0.01%	927
2024 Q3	$466K	Sell	9,607 -2,143	-18%	-$94K	﹤0.01%	1469
2024 Q2	$470K	Buy	11,750 +5,521	+89%	+$229K	﹤0.01%	1513
2024 Q1	$274K	Buy	+6,229	New	+$322K	﹤0.01%	1684
2023 Q1	–	Sell	-16,398	Closed	-$459K	–	2065
2022 Q4	$459K	Sell	16,398 -16,502	-50%	-$479K	﹤0.01%	1573
2022 Q3	$924K	Buy	32,900 +25,100	+322%	+$820K	0.01%	1324
2022 Q2	$271K	Sell	7,800 -14,700	-65%	-$525K	﹤0.01%	1729
2022 Q1	$807K	Buy	+22,500	New	+$638K	0.01%	1100
2020 Q1	–	Sell	-70,179	Closed	-$1.35M	–	1117
2019 Q4	$1.35M	Buy	+70,179	New	+$1.35M	0.03%	423
2019 Q3	–	Sell	-17,000	Closed	-$358K	–	1007
2019 Q2	$358K	Sell	17,000 -26,500	-61%	-$554K	0.01%	729
2019 Q1	$888K	Buy	+43,500	New	+$975K	0.03%	534
2017 Q1	–	Sell	-25,561	Closed	-$470K	–	585
2016 Q4	$470K	Buy	+25,561	New	+$497K	0.06%	349